These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20572010)

  • 21. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.
    Bienengraeber M; Olson TM; Selivanov VA; Kathmann EC; O'Cochlain F; Gao F; Karger AB; Ballew JD; Hodgson DM; Zingman LV; Pang YP; Alekseev AE; Terzic A
    Nat Genet; 2004 Apr; 36(4):382-7. PubMed ID: 15034580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial subproteomic analysis of a constitutively active Rac1-expressing transgenic mouse with lethal myocardial hypertrophy.
    Buscemi N; Murray C; Doherty-Kirby A; Lajoie G; Sussman MA; Van Eyk JE
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2325-33. PubMed ID: 16155095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function.
    Ohno N; Fedak PW; Weisel RD; Mickle DA; Fujii T; Li RK
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1537-48. PubMed ID: 14666030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy.
    Barefield DY; Puckelwartz MJ; Kim EY; Wilsbacher LD; Vo AH; Waters EA; Earley JU; Hadhazy M; Dellefave-Castillo L; Pesce LL; McNally EM
    Circulation; 2017 Oct; 136(16):1477-1491. PubMed ID: 28778945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myotrophin in human cardiomyopathic heart.
    Sil P; Misono K; Sen S
    Circ Res; 1993 Jul; 73(1):98-108. PubMed ID: 8508536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the heart mitochondrial proteome in a desmin null heart failure model.
    Fountoulakis M; Soumaka E; Rapti K; Mavroidis M; Tsangaris G; Maris A; Weisleder N; Capetanaki Y
    J Mol Cell Cardiol; 2005 Mar; 38(3):461-74. PubMed ID: 15733906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.
    Yamada S; Kane GC; Behfar A; Liu XK; Dyer RB; Faustino RS; Miki T; Seino S; Terzic A
    J Physiol; 2006 Dec; 577(Pt 3):1053-65. PubMed ID: 17038430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCNJ11 knockout morula re-engineered by stem cell diploid aggregation.
    Nelson TJ; Martinez-Fernandez A; Terzic A
    Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):269-76. PubMed ID: 18977736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of monkey embryonic stem cell during differentiation.
    Nasrabadi D; Rezaei Larijani M; Pirhaji L; Gourabi H; Shahverdi A; Baharvand H; Salekdeh GH
    J Proteome Res; 2009 Mar; 8(3):1527-39. PubMed ID: 19226164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome.
    Arrell DK; Rosenow CS; Yamada S; Behfar A; Terzic A
    NPJ Regen Med; 2020; 5():5. PubMed ID: 32194990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced heart lipid peroxidation precedes cardiac dilatation in turkeys with naturally occurring cardiomyopathy.
    Lax D; Zhang SL; Li Y; Williams L; Staley NA; Noren GR; Einzig S
    Cardiovasc Res; 1990 Jul; 24(7):540-6. PubMed ID: 2208207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flk1(+) cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model.
    Baba S; Heike T; Yoshimoto M; Umeda K; Doi H; Iwasa T; Lin X; Matsuoka S; Komeda M; Nakahata T
    Cardiovasc Res; 2007 Oct; 76(1):119-31. PubMed ID: 17560966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice.
    Oliveira AC; Melo MB; Motta-Santos D; Peluso AA; Souza-Neto F; da Silva RF; Almeida JFQ; Canta G; Reis AM; Goncalves G; Cerri G; Coutinho D; Guedes de Jesus IC; Guatimosim S; Linhares ND; Alenina N; Bader M; Campagnole-Santos MJ; Santos RAS
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H123-H133. PubMed ID: 30339496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathy.
    Roselló-Lletí E; Tarazón E; Barderas MG; Ortega A; Otero M; Molina-Navarro MM; Lago F; González-Juanatey JR; Salvador A; Portolés M; Rivera M
    PLoS One; 2014; 9(11):e112971. PubMed ID: 25397948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Signature of Nitroso-Redox Balance in Idiopathic Dilated Cardiomyopathies.
    Menazza S; Aponte A; Sun J; Gucek M; Steenbergen C; Murphy E
    J Am Heart Assoc; 2015 Sep; 4(9):e002251. PubMed ID: 26396203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and function of contractile proteins in human dilated cardiomyopathy.
    Wiegand V; Ebecke M; Figulla H; Schüler S; Kreuzer H
    Clin Cardiol; 1989 Nov; 12(11):656-60. PubMed ID: 2582658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic profiling of the human failing heart after left ventricular assist device support.
    de Weger RA; Schipper ME; Siera-de Koning E; van der Weide P; van Oosterhout MF; Quadir R; Steenbergen-Nakken H; Lahpor JR; de Jonge N; Bovenschen N
    J Heart Lung Transplant; 2011 May; 30(5):497-506. PubMed ID: 21211997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters.
    Kato Y; Iwase M; Ichihara S; Kanazawa H; Hashimoto K; Noda A; Nagata K; Koike Y; Yokota M
    Circ J; 2010 Jan; 74(1):163-70. PubMed ID: 19942785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to Injury.
    Gao Z; Sierra A; Zhu Z; Koganti SR; Subbotina E; Maheshwari A; Anderson ME; Zingman LV; Hodgson-Zingman DM
    PLoS One; 2016; 11(3):e0151337. PubMed ID: 26964104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the human myocardial proteome in inflammatory dilated cardiomyopathy by label-free quantitative shotgun proteomics of heart biopsies.
    Hammer E; Goritzka M; Ameling S; Darm K; Steil L; Klingel K; Trimpert C; Herda LR; Dörr M; Kroemer HK; Kandolf R; Staudt A; Felix SB; Völker U
    J Proteome Res; 2011 May; 10(5):2161-71. PubMed ID: 21417265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.